AI and Ethics in Healthtech: Who is Innovating Most? | Podcast #31
Welcome to Talking Precision Medicine — the podcast in [...]
Rafael Rosengarten joins the Midstage Startup Momentum Podcast with Roland Siebelink
"Build a Great Company and a Great Business Follows" [...]
Genialis Presents Poster on KRAS Expression Signature Validation in Lung Cancer
First research poster by Genialis on KRAS/MAPK therapeutic area [...]
Evaluation of a KRAS gene expression signature in lung cancer
This study evaluates the efficacy of a KRAS gene [...]
People first: building a company that inspires impactful work with Genialis leadership team | Podcast #30
Welcome to Talking Precision Medicine — the podcast in [...]
Xerna™ TME Panel is a machine learning-based transcriptomic biomarker designed to predict therapeutic response in multiple cancers
Abstract: Most predictive biomarkers approved for clinical use measure [...]
Genialis Unveils Expressions Version 3.0, Cloud Software for Faster, More Secure Data Processing and Management
Updated Microservices and Front End Architectures Deliver Vastly Improved [...]
The Xerna™ TME Panel potentially predicts response to a combination of the TLR9 agonist vidutolimod and PD-1 inhibitor pembrolizumab in metastatic melanomas with prior anti-PD-1 treatment
This poster illustrates the potential of the Xerna™ TME [...]
ResponderID™: The Biology-First Machine Learning Platform for Biomarker Discovery
Rarely has a complex gene signature been successfully translated [...]
Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response
Through AI/ML-enabled platform with a biology-first approach, Genialis looks [...]
